C86.11

Clinical Causes: The exact cause of hepatosplenic T-cell lymphoma is not fully understood. It is believed to involve genetic mutations that cause abnormal T-cell growth. Certain infections, such as cytomegalovirus (CMV), have been associated with increased risk in some cases. Immunosuppression, such as from organ transplants or autoimmune diseases, may also contribute to the development.

Key Symptoms: Unexplained fevers Night sweats Weight loss Abdominal pain or discomfort Swelling or enlargement of the liver and spleen Fatigue and weakness

Diagnosis Path: Diagnosing hepatosplenic T-cell lymphoma involves several steps. Medical professionals typically perform blood tests, imaging studies like CT or MRI scans to observe the liver and spleen, and a biopsy of affected tissue. Laboratory analysis of biopsy samples can confirm the presence of abnormal T-cells characteristic of this lymphoma type. Additional tests, such as bone marrow biopsies or spinal taps, may be conducted to check if the disease has spread or to assess the stage of the disease. Since remission status can only be confirmed after appropriate treatment, ongoing medical evaluations are vital.

Treatment Protocols: Treatment options generally include combination chemotherapy, targeted therapy, and in some cases, stem cell or bone marrow transplants. The exact approach depends on the patient's overall health, disease stage, and how they respond to initial treatments. Once in remission, patients usually undergo regular follow-up appointments to monitor for any signs of relapse. Supportive care, including managing side effects and maintaining nutritional health, is also an integral part of the treatment journey.